Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients

Journal of Clinical Microbiology

Volumn 38, Issue 2, 2000, Pages 818-825

  Hogardt, Michael ^a   Trebesius, Karlheinz ^a   Geiger, Anna M ^a   Hornef, Mathias ^a   Rosenecker, Josef ^a   Heesemann, Jürgen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE; RIBOSOME RNA;

ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; OLIGONUCLEOTIDE PROBE; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; THROAT CULTURE;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA; HAEMOPHILUS INFLUENZAE; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA;

EID: 0033980096     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.2.818-825.2000     Document Type: Article

References (23)

1. Amann, R. I., L. Krumholz, and D. Stahl. 1990. Fluorescent oligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology. J. Bacteriol. 172:762-770.
2. Amann, R. I., W. Ludwig, and K.-H. Schleifer. 1995. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol. Rev. 59:225-229.
3. DeLong, E. F., G. S. Wickham, and N. R. Pace. 1989. Phylogenetic strains: ribosomal RNA-based probes for the identification of single cells. Science 243:1360-1363.
4. Denton, M., N. J. Todd, K. G. Kerr, P. M. Hawkey, and J. M. Littlewood. 1998. Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J. Clin. Microbiol. 36:1953-1958.
5. Govan, J. R., J. E. Hugues, and P. Vandamme. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:395-407.
6. Govan, J. R., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
7. Hoiby, N. 1982. Microbiology of lung infections in cystic fibrosis patients. Acta Paediatr. Scand. Suppl. 301:33-54.
8. Isles, A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210.
9. Kempf, V. A. J., K. Trebesius, and I. B. Autenrieth. Rapid identification of microbial pathogens in blood cultures by fluorescently labelled rRNA-targeted oligonucleotides. Ann. Intern. Med., in press.
10. Manz, W., R. Amann, W. Ludwig, M. Wagner, and K.-H. Schleifer. 1992. Phylogenetic oligodeoxynucleotide probes for the major subclasses of proteobacteria: problems and solutions. Syst. Appl. Microbiol. 5:593-600.
11. Pedersen, S. S., N. Hoiby, F. Espersen, and C. Koch. 1992. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax 47:6-13.
12. Roller, C., M. Wagner, R. Amann, W. Ludwig, and K.-H. Schleifer. 1994. In situ probing of gram-positive bacteria with high DNA G+C content using 23S rRNA-targeted oligonucleotides. Microbiology 140:2849-2858.
13. Stoffels, M., R. Amann, W. Ludwig, D. Hekmat, and K.-H. Schleifer. 1998. Bacterial community dynamics during start-up of a trickle-bed bioreactor degrading aromatic compounds. Appl. Environ. Microbiol. 64:930-939.
14. Tablan, O. C., T. L. Chorba, D. V. Schidlow, J. W. White, K. A. Hardy, P. H. Gilligan, W. M. Morgan, L. A. Carson, W. J. Martone, J. M. Jason, and W. R. Jarvis. 1985. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J. Pediatr. 107:382-387.
15. Thomassen, M. J., C. A. Demko, C. F. Doershuk, R. C. Stern, and J. D. Klingen. 1986. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am. Rev. Respir. Dis. 134:669-671.
16. Thomassen, M. J., C. A. Demko, J. D. Klinger, and R. C. Stern. 1995. Pseudomonas cepacia colonization among patients with cystic fibrosis: a new opportunist. Am. Rev. Respir. Dis. 131:791-796.
17. Trebesius, K., D. Harmsen, A. Rakin, J. Schmelz, and J. Heesemann. 1998. Developement of rRNA-targeted PCR and in situ hybridization with fluorescently labelled oligonucleotides for detection of Yersinia species. J. Clin. Microbiol. 36:2557-2564.
18. Tsui, L. C., M. Buchwald, D. Barker, J. C. Braman, R. Knowlton, J. W. Schumm, H. Eiberg, J. Mohr, D. Kennedy, N. Plavsic, et al. 1985. Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science 230:1054-1057.
19. Valerius, N. H., C. Koch, and N. Hoiby. 1991. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 338:725-726.
20. Vandamme, P., B. Holmes, M. Vancanneyt, T. Coenye, B. Hoste, R. Coopman, H. Revets, S. Lauwers, M. Gillis, M. Kersters, and J. R. Govan. 1997. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int. J. Syst. Bacteriol. 47:1188-1200.
21. Vazquez, C., M. Municio, M. Corera, L. Gaztelurrutia, A. Sojo, and J. C. Vitoria. 1993. Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Acta Paediatr. 82:308-309.
22. Wood, R. E., T. F. Boat, and C. F. Doershuk. 1976. State of the art: cystic fibrosis. Am. Rev. Respir. Dis. 113:833-878.
23. Zach, M. S. 1990. Lung disease in cystic fibrosis - an updated concept. Pediatr. Pulmonol. 8:188-202.